284 related articles for article (PubMed ID: 26905935)
1. Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.
Zhang P; Wang C; Zhao J; Xiao A; Shen Q; Li L; Li J; Zhang J; Min Q; Chen J; Chen HY; Zhu JJ
ACS Nano; 2016 Mar; 10(3):3637-47. PubMed ID: 26905935
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
Han L; Tang C; Yin C
Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552
[TBL] [Abstract][Full Text] [Related]
3. DNA-hybrid-gated multifunctional mesoporous silica nanocarriers for dual-targeted and microRNA-responsive controlled drug delivery.
Zhang P; Cheng F; Zhou R; Cao J; Li J; Burda C; Min Q; Zhu JJ
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2371-5. PubMed ID: 24470397
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
5. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
Jia HZ; Zhang W; Zhu JY; Yang B; Chen S; Chen G; Zhao YF; Feng J; Zhang XZ
J Control Release; 2015 Oct; 216():9-17. PubMed ID: 26272764
[TBL] [Abstract][Full Text] [Related]
6. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
[TBL] [Abstract][Full Text] [Related]
7. A multi-stimuli responsive gold nanocage-hyaluronic platform for targeted photothermal and chemotherapy.
Wang Z; Chen Z; Liu Z; Shi P; Dong K; Ju E; Ren J; Qu X
Biomaterials; 2014 Dec; 35(36):9678-88. PubMed ID: 25176062
[TBL] [Abstract][Full Text] [Related]
8. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
Li Z; Zhang L; Tang C; Yin C
Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy.
Chen W; Yuan Y; Cheng D; Chen J; Wang L; Shuai X
Small; 2014 Jul; 10(13):2678-87. PubMed ID: 24668891
[TBL] [Abstract][Full Text] [Related]
10. An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release.
Lv R; Yang P; He F; Gai S; Yang G; Dai Y; Hou Z; Lin J
Biomaterials; 2015 Sep; 63():115-27. PubMed ID: 26093792
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
12. Yolk-Shell Structured Au Nanostar@Metal-Organic Framework for Synergistic Chemo-photothermal Therapy in the Second Near-Infrared Window.
Deng X; Liang S; Cai X; Huang S; Cheng Z; Shi Y; Pang M; Ma P; Lin J
Nano Lett; 2019 Oct; 19(10):6772-6780. PubMed ID: 31496257
[TBL] [Abstract][Full Text] [Related]
13. A Tailored DNA Nanoplatform for Synergistic RNAi-/Chemotherapy of Multidrug-Resistant Tumors.
Liu J; Song L; Liu S; Zhao S; Jiang Q; Ding B
Angew Chem Int Ed Engl; 2018 Nov; 57(47):15486-15490. PubMed ID: 30288887
[TBL] [Abstract][Full Text] [Related]
14. In situ amplification of intracellular microRNA with MNAzyme nanodevices for multiplexed imaging, logic operation, and controlled drug release.
Zhang P; He Z; Wang C; Chen J; Zhao J; Zhu X; Li CZ; Min Q; Zhu JJ
ACS Nano; 2015 Jan; 9(1):789-98. PubMed ID: 25525669
[TBL] [Abstract][Full Text] [Related]
15. Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes.
Li Q; Tang Q; Zhang P; Wang Z; Zhao T; Zhou J; Li H; Ding Q; Li W; Hu F; Du Y; Yuan H; Chen S; Gao J; Zhan J; You J
Biomaterials; 2015 Jul; 57():1-11. PubMed ID: 25956192
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and Indocyanine Green Loaded Hybrid Bicelles for Fluorescence Imaging Guided Synergetic Chemo/Photothermal Therapy.
Lin L; Liang X; Xu Y; Yang Y; Li X; Dai Z
Bioconjug Chem; 2017 Sep; 28(9):2410-2419. PubMed ID: 28810733
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
18. Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect.
Kwon HJ; Byeon Y; Jeon HN; Cho SH; Han HD; Shin BC
J Control Release; 2015 Oct; 216():132-9. PubMed ID: 26247553
[TBL] [Abstract][Full Text] [Related]
19. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems.
Liu Y; Gao FP; Zhang D; Fan YS; Chen XG; Wang H
J Control Release; 2014 Jan; 173():140-7. PubMed ID: 24188958
[TBL] [Abstract][Full Text] [Related]
20. Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy.
Ren Y; Wang R; Gao L; Li K; Zhou X; Guo H; Liu C; Han D; Tian J; Ye Q; Hu YT; Sun D; Yuan X; Zhang N
J Control Release; 2016 Apr; 228():74-86. PubMed ID: 26956593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
